Saba Capital Management purchased 4,340 common shares of Gabelli Healthcare & WellnessRx Trust for $43,617 at $10.05 per share, according to a regulatory filing.
The transaction, completed on August 27, 2026, was reported in a Form 4 filed with the U.S. Securities and Exchange Commission. The hedge fund, already a 10% owner of the trust, now holds 2,155,133 shares indirectly.
Gabelli Healthcare & WellnessRx Trust, which trades on the NASDAQ under the ticker GRX, focuses on investments in healthcare and wellness-related assets. The latest acquisition represents a marginal increase in Saba Capital’s existing position, with no immediate strategic implications disclosed in the filing.
